Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$120.40 2.81 (2.28%) as of 4:30 Fri 12/12


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 150.50(B)
Last Volume: 6,767,750 Avg Vol: 8,372,410
52 Week Range: $89.14 - $128.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  425
Guru Rank Value     : 4.8
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 135,757 212,257 569,042 1,114,354
Total Sell Value $16,616,331 $25,377,037 $61,568,606 $110,876,634
Total People Sold 6 6 6 7
Total Sell Transactions 13 23 34 50
End Date 2025-09-14 2025-06-13 2024-12-13 2023-12-14

   
Records found: 928
  Page 1 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-12-10 4 D $121.34 $220,111 D/D (1,814) 109,221     -
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-12-10 4 OE $0.00 $0 D/D 3,842 111,035     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-12-10 4 D $121.34 $598,328 D/D (4,931) 576,698     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-12-10 4 OE $0.00 $0 D/D 10,426 581,629     -
   Dickinson Andrew D Chief Financial Officer   •       –      –    2025-12-10 4 D $121.34 $211,738 D/D (1,745) 156,503     -
   Dickinson Andrew D Chief Financial Officer   •       –      –    2025-12-10 4 OE $0.00 $0 D/D 3,693 158,248     -
   Bluestone Jeffrey Director   –       •      –    2025-11-28 4 S $125.08 $625,400 D/D (5,000) 8,920 2%     
   Bluestone Jeffrey Director   –       •      –    2025-11-28 4 OE $64.92 $324,600 D/D 5,000 13,920     -
   Kramer Kelly A. Director   –       •      –    2025-11-28 4 AS $127.10 $356,516 D/D (2,805) 1,339 -4%     
   Kramer Kelly A. Director   –       •      –    2025-11-28 4 OE $81.00 $227,205 D/D 2,805 4,144     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-11-28 4 AS $125.91 $1,265,444 D/D (10,000) 571,203 -4%     
   Kramer Kelly A. Director   –       •      –    2025-11-26 4 AS $127.11 $356,671 D/D (2,806) 1,339 -5%     
   Kramer Kelly A. Director   –       •      –    2025-11-26 4 OE $81.00 $227,286 D/D 2,806 4,145     -
   Dickinson Andrew D Chief Financial Officer   •       –      –    2025-11-17 4 AS $125.23 $313,075 D/D (2,500) 154,555 -2%     
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-11-17 4 AS $125.83 $3,524,173 D/D (28,000) 107,193 -2%     
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-11-17 4 OE $66.64 $1,666,000 D/D 25,000 135,193     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       –      –    2025-11-12 4 AS $122.30 $6,590,487 D/D (53,646) 43,676 -2%     
   Telman Deborah H EVP, Corporate Affairs & GC   •       –      –    2025-11-12 4 OE $60.75 $3,505,885 D/D 53,646 44,176     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-10-28 4 AS $118.82 $1,193,926 D/D (10,000) 581,203 3%     
   Telman Deborah H EVP, Corporate Affairs & GC   •       –      –    2025-10-25 4 D $120.94 $29,147 D/D (241) 43,676     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       –      –    2025-10-25 4 OE $0.00 $0 D/D 515 43,917     -
   Dickinson Andrew D Chief Financial Officer   •       –      –    2025-10-15 4 AS $118.08 $295,200 D/D (2,500) 157,055 2%     
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-10-15 4 AS $118.08 $354,240 D/D (3,000) 110,193 2%     
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-09-29 4 AS $111.47 $1,116,564 D/D (10,000) 591,203 8%     
   Mercier Johanna Chief Commercial Officer   •       –      –    2025-09-15 4 AS $113.57 $340,710 D/D (3,000) 113,193 8%     
  928 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us